Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Gallagher

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Proteomics. Clinical Applications|December 8, 2010
Focus on cancer proteomics: from discovery towards validationWilliam M Gallagher
Breast Cancer Research : BCR|March 12, 2008
Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'Donal J Brennan, William M Gallagher
Proteomics|July 19, 2012
Focus on cancer proteomicsBen C Collins, William M Gallagher
Expert Opinion on Medical Diagnostics|March 19, 2013
Selected highlights of the Third Annual Biomarkers Congress: from discovery to validation in the drug development arenaCaroline A Currid, William M Gallagher
Drug Discovery Today|April 3, 2009
Omic profiling for drug safety assessment: current trends and public-private partnershipsWilliam M Gallagher, David Tweats, Jochen Koenig
Drug Discovery Today|June 28, 2011
Truncated HER2: implications for HER2-targeted therapeuticsRadoslaw Zagozdzon, William M Gallagher, John Crown
Clinical Chemistry|October 16, 2015
The Role of Exosomes in Breast CancerMichelle C Lowry, William M Gallagher, Lorraine O'Driscoll
Breast Cancer Research : BCR|May 1, 2015
A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancerLaoighse Mulrane, William M Gallagher, Darran P O'Connor
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2016
Assessment of Significance of Novel Proteins in Breast Cancer Using Tissue Microarray TechnologyLaoighse Mulrane, William M Gallagher, Darran P O'Connor
Cancers|February 12, 2020
Clinical Decision Support Systems in Breast Cancer: A Systematic ReviewClaudia Mazo, Cathriona Kearns, Catherine Mooney, et al.
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Proteomics. Clinical Applications|December 8, 2010
Focus on cancer proteomics: from discovery towards validationWilliam M Gallagher
Breast Cancer Research : BCR|March 12, 2008
Prognostic ability of a panel of immunohistochemistry markers - retailoring of an 'old solution'Donal J Brennan, William M Gallagher
Proteomics|July 19, 2012
Focus on cancer proteomicsBen C Collins, William M Gallagher
Expert Opinion on Medical Diagnostics|March 19, 2013
Selected highlights of the Third Annual Biomarkers Congress: from discovery to validation in the drug development arenaCaroline A Currid, William M Gallagher
Drug Discovery Today|April 3, 2009
Omic profiling for drug safety assessment: current trends and public-private partnershipsWilliam M Gallagher, David Tweats, Jochen Koenig
Drug Discovery Today|June 28, 2011
Truncated HER2: implications for HER2-targeted therapeuticsRadoslaw Zagozdzon, William M Gallagher, John Crown
Clinical Chemistry|October 16, 2015
The Role of Exosomes in Breast CancerMichelle C Lowry, William M Gallagher, Lorraine O'Driscoll
Breast Cancer Research : BCR|May 1, 2015
A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancerLaoighse Mulrane, William M Gallagher, Darran P O'Connor
Methods in Molecular Biology (Clifton, N.J.)|November 1, 2016
Assessment of Significance of Novel Proteins in Breast Cancer Using Tissue Microarray TechnologyLaoighse Mulrane, William M Gallagher, Darran P O'Connor
Cancers|February 12, 2020
Clinical Decision Support Systems in Breast Cancer: A Systematic ReviewClaudia Mazo, Cathriona Kearns, Catherine Mooney, et al.
Pageof 22